Learning strategies for laypeople to participate in health technology assessment: a scoping review [0.03%]
普通人参与卫生技术评估的学习策略：综述研究
Alex Itaborahy,Quenia Morais,Leny Frossard et al.
Alex Itaborahy et al.
Ethics domains in full health technology assessment reports: an attempt to begin mapping the field [0.03%]
全面健康技术评估报告中的伦理领域：尝试开始绘制该领域的地图
Hannes Kahrass,Antje Schnarr,Clovis Mariano Faggion Jr et al.
Hannes Kahrass et al.
Introduction: Health technology assessment (HTA) reports are written for healthcare decision makers, particularly in relation to reimbursement/pricing, and are intended to assess clinical effectiveness, safety, and cost. ...
Towards institutionalizing HTA in Ethiopia: using a political economy analysis to explore stakeholder perspectives and assessing capacity needs [0.03%]
基于政治经济学分析的卫生技术评估制度化研究——以埃塞俄比亚为例
Daniel Asfaw Erku,Ararso Desalegn,Tesfaye Mesele Mekonnen et al.
Daniel Asfaw Erku et al.
Real-world evidence to support health technology assessment and payer decision making: is it now or never? [0.03%]
真实世界证据支持卫生技术评估和支付方决策：现在还是从来没有？
Linda A Murphy,Ron Akehurst,David Cunningham et al.
Linda A Murphy et al.
Objectives: The aim of this policy article is twofold: (i) to provide a summary and update of recent important policy developments, in particular relevant guidance on the use of real-world data/real-world evidence (RWD/RW...
"Blanket rules just don't work": Qualitative exploration of the relative value of child and adult Quality Adjusted Life Year (QALY) gains for health technology assessment [0.03%]
“一刀切的规定根本行不通”：探索儿童和成人调整生命年(QALY)收益在卫生技术评估中的相对价值的定性研究
Marcus Sellars,Joanna Coast,Emily Lancsar et al.
Marcus Sellars et al.
PATIENT ENGAGEMENT FOR THE DEVELOPMENT OF EQUITY-FOCUSED HEALTH TECHNOLOGY ASSESSMENT (HTA) RECOMMENDATIONS: A CASE STUDY OF TWO CANADIAN HTA ORGANIZATIONS [0.03%]
促进股权焦点的卫生技术评估(H_tA)建议发展的患者参与：一个加拿大H_tA组织案例分析
Rosiane Simeon,Abdulah Al Ameer,Janet H Roberts et al.
Rosiane Simeon et al.
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia [0.03%]
标題翻譯成中文：校准过渡概率以模拟印度尼西亚早期乳腺癌辅助曲妥珠单抗的生存模型
Arie Rahadi,Rizki Tsalatshita Khair Mahardya,Putri Listiani et al.
Arie Rahadi et al.
Objectives: Cost-effectiveness models fully informed by real-world epidemiological parameters yield the best results, but they are costly to obtain. Model calibration using real-world data/evidence (RWD/E) on routine heal...
THE POTENTIAL OF THE HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT. Results of a world-wide survey [0.03%]
基于医院的健康技术评估的潜力。全球调查结果
Rossella Di Bidino,Iga Lipska,Monica Kukla et al.
Rossella Di Bidino et al.
NAVIGATING CHANGE: A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT REFORMS ACROSS AGENCIES - PROCESSES, DRIVERS, AND INTERDEPENDENCIES [0.03%]
应对变革：机构间卫生技术评估改革的比较分析-过程，驱动因素和相互依赖性
Gayathri Kumar,Priscila Radu,Patricia Cubi-Molla et al.
Gayathri Kumar et al.
HTA RESPONSIVENESS TO TODAY'S CHALLENGES TO HEALTH SYSTEMS: A RESPONSIBLE INNOVATION IN HEALTH PERSPECTIVE [0.03%]
面对当前卫生系统的挑战，HTA的响应性：基于健康责任创新的观点
P Lehoux,I Ganache,O Demers-Payette et al.
P Lehoux et al.